Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.57 USD
−10.23 M USD
0.00 USD
23.54 M
About RenovoRx, Inc.
Sector
CEO
Shaun R. Bagai
Headquarters
Los Altos
Website
Founded
2009
FIGI
BBG005XWWZK6
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Los Altos, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RNXT is 1.17 USD — it has increased by 7.21% in the past 24 hours. Watch RenovoRx, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange RenovoRx, Inc. stocks are traded under the ticker RNXT.
RNXT stock has risen by 3.48% compared to the previous week, the month change is a 20.18% rise, over the last year RenovoRx, Inc. has showed a 88.71% increase.
We've gathered analysts' opinions on RenovoRx, Inc. future price: according to them, RNXT price has a max estimate of 8.25 USD and a min estimate of 3.50 USD. Watch RNXT chart and read a more detailed RenovoRx, Inc. stock forecast: see what analysts think of RenovoRx, Inc. and suggest that you do with its stocks.
RNXT reached its all-time high on Aug 30, 2021 with the price of 16.74 USD, and its all-time low was 0.53 USD and was reached on Dec 6, 2023. View more price dynamics on RNXT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
RNXT stock is 17.84% volatile and has beta coefficient of 2.58. Track RenovoRx, Inc. stock price on the chart and check out the list of the most volatile stocks — is RenovoRx, Inc. there?
Today RenovoRx, Inc. has the market capitalization of 28.56 M, it has increased by 9.17% over the last week.
Yes, you can track RenovoRx, Inc. financials in yearly and quarterly reports right on TradingView.
RenovoRx, Inc. is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
RNXT earnings for the last quarter are −0.10 USD per share, whereas the estimation was −0.12 USD resulting in a 14.29% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about RenovoRx, Inc. earnings.
RenovoRx, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
RNXT net income for the last quarter is −2.47 M USD, while the quarter before that showed −2.39 M USD of net income which accounts for −3.43% change. Track more RenovoRx, Inc. financial stats to get the full picture.
No, RNXT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 8.00 employees. See our rating of the largest employees — is RenovoRx, Inc. on this list?
Like other stocks, RNXT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RenovoRx, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RenovoRx, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RenovoRx, Inc. stock shows the sell signal. See more of RenovoRx, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.